N0821: A Phase Ii First-Line Study of A Combination of Pemetrexed (P), Carboplatin (C), and Bevacizumab (B) in Elderly Patients with Good Performance Status (ps < 2).
JOURNAL OF CLINICAL ONCOLOGY（2012）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要